Predicting survival in idiopathic pulmonary fibrosis: Scoring system and survival model

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 7, 2001, Pages 1171-1181

  King Jr , Talmadge E ^a   Tooze, Janet A ^b   Schwarz, Marvin I ^b   Brown, Kevin R ^b   Cherniack, Reuben M ^b  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Idiopathic pulmonary fibrosis; Prospective studies; Pulmonary function tests; Smoking physiopathology; Survival rate; Usual interstitial pneumonia

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IDIOPATHIC DISEASE; INTERSTITIAL PNEUMONIA; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; QUESTIONNAIRE; SCORING SYSTEM; SMOKING; SURVIVAL RATE;

EID: 0035482002     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.7.2003140     Document Type: Article

References (34)

1. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease
2. Cryptogenic fibrosing alveolitis: Response to corticosteroid treatment and its effect on survival
3. Cryptogenic fibrosing alveolitis: Clinical features and their influence on survival
4. Prognosis of cryptogenic fibrosing alveolitis
5. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis
6. Idiopatic pulmonary fibrosis. Clinical relevance of pathologic classification
7. Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement
8. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis
9. Idiopathic pulmonary fibrosis: Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy
10. A new method for measuring airway resistance in man using a body plethysmograph: Values in normal subjects and in patients with respiratory disease
11. Respiratory function tests. Normal value at medium altitude and the prediction of normal results
12. Spirometric standard for healthy non-smoking adult
13. A standardized breath-holding technique for the clinical measurement of diffusing capacity of the lung for carbon monoxide
14. Standardized single breath values for carbon monoxide diffusing capacity
15. Lung distensibility. The static pressure-volume curve of the lungs and its use in clinical assessment
16. Decreased pulmonary distensibility in fibrosing alveolitis and its relation to decreased lung volume
17. Correlation of structure and function in idiopathic pulmonary fibrosis
18. Ideal alveolar air and the analysis of ventilation-perfusion relationships in the lungs
19. Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis
20. Idiopathic pulmonary fibrosis: The quantitative assessment of lung pathology. Comparison of a semiquantitative versus a morphometric histopathologic scoring system
21. Bin Daud 1. Case-weighted measures of influence for proportional hazards regression
22. A new look at the statistical model identification
23. The relation between histopathological features and mortality in a prospective study of patients with idiopathic pulmonary fibrosis
24. Determinants of survival in idiopathic pulmonary fibrosis
25. Natural history and treated course of usual and desquamative interstitial pneumonia
26. British Thoracic Society study of cryptogenic fibrosing alveolitis: Current presentation and initial management
27. Cigarette smoking: A risk factor for idiopathic pulmonary fibrosis
28. The impact of smoking on mechanical properties of the lungs in idiopathic pulmonary fibrosis and sarcoidosis
29. Cigarette smoke inhibits lung fibroblast proliferation and chemotaxis
30. Fibrosing alveolitis: Chest radiology and CT as predictors of clinical and functional impairment ar follow-up in 26 patients
31. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis
32. Idiopathic nonspecific interstitial pneumonia/fibrosis: Comparison with idiopathic pulmonary fibrosis and BOOP